Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TP53 target 3 family member H, pseudogene (TP53TG3HP) is classified as a pseudogene—an inactive segment of DNA resembling a gene but unable to code for a functional protein due to evolutionary mutations[2][4]. Pseudogenes typically do not serve as receptors, enzymes, or other conventional therapeutic targets. While some pseudogenes may influence cellular processes via noncoding RNAs, no evidence suggests TP53TG3HP has a direct biological function, involvement in disease, or role as a drug target[2][4][1]. The “H” member designation and abbreviation are standardized by genome databases, but no functional or clinical relevance has been reported for this specific pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TP53 target 3 family member H, pseudogene (TP53TG3HP).